Stay updated on Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.3 to v3.5.4, indicating a minor maintenance/version update to the page.
    Difference
    0.1%
    Check dated 2026-05-15T06:45:27.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The study record now shows Completed and Results Posted, with new timing details and the addition of outcome measures for adverse events and disease-free survival. Old status fields and timepoint labels such as Active, not recruiting and 1 year have been removed to reflect the current record.
    Difference
    2%
    Check dated 2026-05-08T11:11:38.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page’s revision/version label has been updated from v3.5.2 to v3.5.3, indicating an interface or backend release without altering the study record content.
    Difference
    0.1%
    Check dated 2026-04-24T06:00:04.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    - Website revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:35:55.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0; this update does not change any study details, eligibility criteria, locations, or outcomes displayed on the page.
    Difference
    0.1%
    Check dated 2026-03-19T06:13:39.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Revision number updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:42:32.000Z thumbnail image

Stay in the know with updates to Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page.